SAIDS Vaccines

"SAIDS Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Vaccines or candidate vaccines designed to prevent SAIDS; (SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME); and containing inactivated SIMIAN IMMUNODEFICIENCY VIRUS or type D retroviruses or some of their component antigens.

Descriptor ID

D018449

MeSH Number(s)

D20.215.894.899.790

Concept/Terms

SAIDS Vaccines

SIV Vaccine

Below are MeSH descriptors whose meaning is more general than "SAIDS Vaccines".

Chemicals and Drugs [D]
Complex Mixtures [D20]
Biological Agents [D20.215]
Vaccines [D20.215.894]
Viral Vaccines [D20.215.894.899]
SAIDS Vaccines [D20.215.894.899.790]

Below are MeSH descriptors whose meaning is more specific than "SAIDS Vaccines".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "SAIDS Vaccines" by people in Harvard Catalyst Profiles by year, and whether "SAIDS Vaccines" was a major or minor topic of these publication.

Bar chart showing 115 publications over 29 distinct years, with a maximum of 8 publications in 2000 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	0	1
1995	3	0	3
1996	3	0	3
1997	5	0	5
1998	2	0	2
1999	3	0	3
2000	7	1	8
2001	2	2	4
2002	6	0	6
2003	4	0	4
2004	1	2	3
2005	0	1	1
2006	3	1	4
2007	2	1	3
2008	6	0	6
2009	5	0	5
2010	2	0	2
2011	3	0	3
2012	7	0	7
2013	4	0	4
2014	2	2	4
2015	5	0	5
2016	5	1	6
2017	2	0	2
2018	4	0	4
2019	6	0	6
2020	8	0	8
2021	2	0	2
2022	1	0	1

Below are the most recent publications written about "SAIDS Vaccines" by people in Profiles.

Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant. JCI Insight. 2022 10 10; 7(19).

View in: PubMed
Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition. J Virol. 2021 06 24; 95(14):e0033021.

View in: PubMed
Oral Vaccination Approaches for Anti-SHIV Immunity. Front Immunol. 2021; 12:702705.

View in: PubMed
Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infection. J Clin Invest. 2020 12 01; 130(12):6429-6442.

View in: PubMed
Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome. J Virol. 2020 11 23; 94(24).

View in: PubMed
Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity. AIDS Res Hum Retroviruses. 2020 12; 36(12):984-997.

View in: PubMed
Therapeutic vaccination of SIV-infected, ART-treated infant rhesus macaques using Ad48/MVA in combination with TLR-7 stimulation. PLoS Pathog. 2020 10; 16(10):e1008954.

View in: PubMed
Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques. Cell. 2020 10 01; 183(1):185-196.e14.

View in: PubMed
Cervico-Vaginal Inflammatory Cytokine and Chemokine Responses to Two Different SIV Immunogens. Front Immunol. 2020; 11:1935.

View in: PubMed
Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection. J Infect Dis. 2020 06 16; 222(1):44-53.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

J Virol
PLoS Pathog
AIDS Res Hum Retroviruses
Virology
J Immunol
Nature
Nat Med
PLoS One
Retrovirology
J Infect Dis